SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-005031
Filing Date
2023-03-01
Accepted
2023-03-01 08:45:23
Documents
15
Period of Report
2023-03-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20230228_8k.htm   iXBRL 8-K 25902
2 EXHIBIT 99.1 ex_481895.htm EX-99.1 15101
7 mbrx20230228_8kimg001.jpg GRAPHIC 3372
  Complete submission text file 0001437749-23-005031.txt   187707

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230301.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230301_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230301_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230301_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20230228_8k_htm.xml XML 2562
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 23689944
SIC: 2834 Pharmaceutical Preparations